Finance

Lists
SHRX:CVE
Sharp Therapeutics Corp
CA$1.37
0.00%
(0.00) 1D
Sep 21, 10:31:12 AM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for SHRX...
Mkt. cap
43.26M
Avg. vol.
0.00
Volume
0.00
52-wk high
CA$5.00
52-wk low
CA$0.91
EPS
-CA$0.28
Mkt. cap
43.26M
Avg. vol.
0.00
Volume
0.00
52-wk high
CA$5.00
52-wk low
CA$0.91
EPS
-CA$0.28
News stories
From web sources and news partners
About Sharp Therapeutics Corp
CEO-
Employees-
Founded2021
HeadquartersPittsburgh, Pennsylvania, United States
SectorHealth Care
IndustryPharmaceutical industry
Websitesharptx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
684.43K
975.47K
665.49K
665.49K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
319.91K
589.04K
556.39K
556.39K
Operating expense
1.04M
1.72M
1.45M
1.45M
Total operating expenses
1.04M
1.72M
1.45M
1.45M
Operating income
-1.04M
-1.72M
-1.45M
-1.45M
Other non operating income
-6.86K
-632.12K
-8.58K
-8.58K
EBT including unusual items
-1.09M
-2.39M
-1.22M
-1.22M
EBT excluding unusual items
-1.09M
-2.39M
-1.50M
-1.50M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.09M
-2.39M
-1.22M
-1.22M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
82.00
16.00
16.00
Interest expense
-41.61K
-41.28K
-40.62K
-40.62K
Net interest expenses
-41.61K
-41.20K
-40.60K
-40.60K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.03M
-1.72M
-1.45M
-1.45M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps